Nordhealth AS - Primary insider notices

Helsinki, Finland, 29 December 2023: Charles MacBain, the CEO and primary insider of Nordhealth AS (the "Company"), has today exchanged 5,505,319 class A shares in the Company for an equal number of class B shares. The exchange was executed in two separate transactions with family members who held B shares. Following the transactions, Charles MacBain owns 268,187 class A shares in the Company. In addition, he holds 29 794 638 class B shares, in total 30,062,825 shares. Please refer to the attached notifications in accordance with the Market Abuse Regulation article 19 for further details. For further information, please contact: Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200 About Nordhealth Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS company on a mission to redefine digital healthcare. We build software that empower veterinary and therapy professionals to provide the best possible care experiences to their patients. Our products serve more than 50,000 veterinary and therapy professionals across 13,000 clinics and hospitals located in over 30 countries. Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the Nordic region and a growing presence internationally, with more than 380 employees working either remotely or from offices (collaboration hubs). Visit the company's website at nordhealth.com (http://www.nordhealth.com.